Medical Technologies Recognised at Galien Awards

We all know, all of us in the medical business, who Galen was, right? No? Well, just in case you didn’t, I did! He was probably the greatest contributor to modern medicine, the successor to Hippocrates, and a man who crossed the boundaries between being a practitioner, an academic, an anatomist and the true forefather of experimental research.

Only appropriate then that there should exist something called the Galien Foundation and that it should, as one of its functions, recognise the pinnacle of technical, scientific and clinical research skills necessary to develop innovative medicines and devices.

Now in its eighth year of formally dishing out its Galien USA accolades, nominees include biomedical products across three categories – biotechnology, pharmaceutical, and technology products – that advance the human condition and which were approved by the U.S. FDA during the past five years.

Being essentialy a device and technology site we’ll skip over the pharmaceutical bit, straight to some of the awards for things you might recognise.

The Best Medical Technology nominees include:

  • Allergan’s SERI® Surgical Scaffold, a long term bioresorbable matrix for use in closure of tissue defects in laparoscopic and open procedures.
  • Boston Scientific’s Alair™ Bronchial Thermoplasty System and Precision Spectra™ Spinal Cord Stimulator System
  • Covidien’s superDimension™ Navigation System
  • LDR Holding’s Mobi-C® Cervical Disc
  • Novocure’s NovoTTF™ Therapy
  • Paradigm Spine’s coflex® Interlaminar Stabilization™ device
  • Roche’s Elecsys® Testosterone II
  • Sanofi’s Auvi-Q® (epinephrine injection, USP)
  • Stryker’s Trevo® ProVue™ Retriever for Neurovascular clots
  • and VisionCare’s CentraSight® Implantable Telescope Technology

The Prix Galien USA Committee, comprised of 10 renowned leaders from the biomedical industry and academia, including five Nobel Laureates, is responsible for evaluating nominees. Winners will be honored at the Prix Galien USA Awards Ceremony on October 28, 2014 at 6:30 p.m., at the American Museum of Natural History in New York City.

Chairman comments

“Biomedical research can only exist when there are those who are willing to push innovation, extract understanding, and bring attention to the details,” remarked Bruno Cohen, Chairman of the Galien Foundation. “This year’s nominees are catalysts for the development of disease-altering advances through biopharmaceutical and medical technology innovation. It is upon these values that the Galien Foundation is predicated, and we’re proud to honor those in the field who exemplify these same principles.”

Source: The Galien Foundation, PR Newswire

- in: Categories

Share your thoughts

Your email address will not be published. Required fields are marked *